Cognition Therapeutics (CGTX) Profit After Tax (2020 - 2026)
Cognition Therapeutics (CGTX) reported Profit After Tax of -$8.8 million for Q1 2026, down 4.03% year-over-year from -$9.2 million in Q1 2025, and down 163.89% on a QoQ basis from -$3.3 million in Q4 2025.
Cognition Therapeutics (CGTX) has 7 years of Profit After Tax data on file, last reported at -$8.8 million in Q1 2026.
- Quarterly Profit After Tax fell 4.03% year-over-year to -$8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.8 million (up 28.44% YoY) and the FY2025 annual result came in at -$23.5 million, up 30.86% from the prior year.
- Profit After Tax eased to -$8.8 million in Q1 2026 per CGTX's latest filing, from -$3.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$3.3 million in Q4 2025 and bottomed at -$9.9 million in Q3 2024.
- The 5-year median for Profit After Tax is -$6.7 million (2025), against an average of -$6.7 million.
- The widest annual swing landed in 2022, when Profit After Tax tumbled 1821.08%; it then surged 57.37% in 2025.
- Tracing CGTX's Profit After Tax over 5 years: stood at -$5.2 million in 2022, then slumped by 57.1% to -$8.1 million in 2023, then rose by 3.67% to -$7.8 million in 2024, then surged by 57.37% to -$3.3 million in 2025, then tumbled by 163.89% to -$8.8 million in 2026.
- Per Business Quant, the three latest CGTX Profit After Tax figures stand at -$8.8 million (Q1 2026), -$3.3 million (Q4 2025), and -$4.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -3.63 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | -8.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.82 Mn |
| Dec 31, 2025 | -3.34 Mn |
| Sep 30, 2025 | -4.93 Mn |
| Jun 30, 2025 | -6.73 Mn |
| Mar 31, 2025 | -8.48 Mn |
| Dec 31, 2024 | -7.84 Mn |
| Sep 30, 2024 | -9.94 Mn |
| Jun 30, 2024 | -7.04 Mn |
| Mar 31, 2024 | -9.15 Mn |
| Dec 31, 2023 | -8.14 Mn |
| Sep 30, 2023 | -6.75 Mn |
| Jun 30, 2023 | -4.73 Mn |
| Mar 31, 2023 | -6.17 Mn |
| Dec 31, 2022 | -5.18 Mn |
| Sep 30, 2022 | -6.63 Mn |
| Jun 30, 2022 | -5.75 Mn |
| Mar 31, 2022 | -3.84 Mn |
| Dec 31, 2021 | -7.34 Mn |
| Sep 30, 2021 | -3.11 Mn |
| Jun 30, 2021 | -1.49 Mn |
| Mar 31, 2021 | 223,000.00 |
| Dec 31, 2020 | -1.87 Mn |
| Sep 30, 2020 | -1.79 Mn |